BIT Capital’s Immunogen Inc IMGN Stock Holding History

BIT Capital’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-504,100	Closed	-$2.4M	–	178
2022 Q1	$2.4M	Buy	+504,100	New	+$2.79M	0.21%	50

Other funds holding IMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

BIT Capital's IMGN Position: Q4 2023 in Review

BIT Capital sold out of Immunogen Inc (IMGN) in Q4 2023, closing a stake of 212,852 shares — an estimated $3.38M sold.

BIT Capital first reported a position in IMGN in Q1 2022 and held it in 5 quarters. The position peaked at $3.93M in Q2 2023. 327 funds tracked by Wall St. Rank hold IMGN as of Q4 2023.

BIT Capital reported no remaining Immunogen Inc position as of Q4 2023 after selling out during the quarter.
BIT Capital sold 212,852 Immunogen Inc shares in Q4 2023, an estimated $3.38M.
BIT Capital first reported a position in Immunogen Inc in Q1 2022 and held it in 5 quarters.
BIT Capital's Immunogen Inc position peaked at $3.93M in Q2 2023.
327 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2023.

Based on BIT Capital's 13F filing for Q4 2023, filed 12 Feb 2025.